Stock Scorecard



Stock Summary for Virios Therapeutics Inc (VIRI) - $0.45 as of 4/18/2024 2:26:33 PM EST

Total Score

14 out of 29

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for VIRI

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VIRI

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VIRI

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for VIRI

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for VIRI

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID - Virios Therapeutics ( NASDAQ:VIRI ) 3/26/2024 1:15:00 PM
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID 3/26/2024 1:15:00 PM
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results 2/29/2024 2:15:00 PM
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones 2/28/2024 2:15:00 PM
Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge - Digital World Acq ( NASDAQ:DWAC ) , Archer-Daniels Midland ( NYSE:ADM ) 1/22/2024 7:19:00 PM
Crude Oil Surges Over 2%; US Leading Economic Index Falls In December - Digital World Acq ( NASDAQ:DWAC ) , Archer-Daniels Midland ( NYSE:ADM ) 1/22/2024 5:18:00 PM
US Stocks Higher; Nasdaq Jumps 100 Points - Nuvve Holding ( NASDAQ:NVVE ) , Fisker ( NYSE:FSR ) 1/22/2024 3:15:00 PM
Fibromyalgia Treatment Market Projected to Surpass US$ 2.7 Billion in Revenue by 2033, According to Persistence Market Research 1/18/2024 2:45:00 PM
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID - Virios Therapeutics ( NASDAQ:VIRI ) 1/2/2024 12:05:00 PM
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID 1/2/2024 12:05:00 PM

Financial Details for VIRI

Company Overview

Ticker VIRI
Company Name Virios Therapeutics Inc
Country USA
Description Virios Therapeutics, Inc., a developmental biotechnology company, focuses on developing antiviral therapies to treat diseases associated with an abnormal immune response triggered by a virus. The company is headquartered in Alpharetta, Georgia.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/9/2024

Stock Price History

Last Day Price 0.45
Last Day Price Updated 4/18/2024 2:26:33 PM EST
Last Day Volume 87,126
Average Daily Volume 454,082
52-Week High 2.42
52-Week Low 0.28
Last Price to 52 Week Low 60.71%

Valuation Measures

Trailing PE N/A
Industry PE 100.90
Sector PE 61.34
5-Year Average PE -1.23
Free Cash Flow Ratio 2.65
Industry Free Cash Flow Ratio 12.64
Sector Free Cash Flow Ratio 30.17
Current Ratio Most Recent Quarter 11.62
Total Cash Per Share 0.17
Book Value Per Share Most Recent Quarter 0.20
Price to Book Ratio 2.59
Industry Price to Book Ratio 5.66
Sector Price to Book Ratio 22.08
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 5.48
Sector Price to Sales Ratio Twelve Trailing Months 5.19

Share Statistics

Total Shares Outstanding 19,257,900
Market Capitalization 8,666,055
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 56.76%
Reported EPS 12 Trailing Months -0.28
Reported EPS Past Year 0.00
Reported EPS Prior Year -0.28
Net Income Twelve Trailing Months -5,296,015
Net Income Past Year -5,296,015
Net Income Prior Year -12,247,834
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 415.80%

Balance Sheet

Total Cash Most Recent Quarter 3,316,946
Total Cash Past Year 3,316,946
Total Cash Prior Year 7,030,992
Net Cash Position Most Recent Quarter 3,316,946
Net Cash Position Past Year 3,316,946
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 3,806,894
Total Stockholder Equity Prior Year 7,326,494
Total Stockholder Equity Most Recent Quarter 3,806,894

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.02
MACD Signal 0.02
20-Day Bollinger Lower Band 0.22
20-Day Bollinger Middle Band 0.50
20-Day Bollinger Upper Band 0.78
Beta 1.88
RSI 52.06
50-Day SMA 0.93
200-Day SMA 0.00

System

Modified 4/18/2024 2:26:35 PM EST